Sep 2026 quarter: consolidated revenue up 19.6%, profit after tax up 27.4% year on year
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts more than Nifty Smallcap 250 and 4.2 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Quarter ended 30 Sep 2026, consolidated: revenue INR 873.9 crore versus 730.6 crore a year earlier, up 19.6%; profit after tax INR 193.9 crore versus 152.2 crore, up 27.4%. Operating margin before interest, tax, depreciation and amortisation rose 1.4 points to 32.1%. Also: second interim dividend of INR 5 per share; independent director, pending shareholder approval; up to INR 49.5 crore for the Dubai unit, including up to INR 30 crore for Ghana.
Profit growth and margin gains may support the stock; the dividend aids income, while Dubai funding supports expansion but uses cash.
The filed figures for this quarter have not reached us in XBRL yet, so there is nothing to compute here; the read above is the AI's, from the document. The table appears the moment the figures land.